Pneumonia Clinical Trial
Official title:
ePneumonia: Development of an Electronic Clinical Decision Support System for Community-Onset Pneumonia
The investigators plan to further develop a prototype, evidence-based, electronic clinical decision support system (CDSS) for pneumonia care (ePneumonia) with interoperability across Electronic Health Records in order to improve clinical outcomes and reduce healthcare resource utilization. The specific aims of this study are to evaluate the usability of ePneumonia adapted for Cerner and its impact on clinical, patient-centered and healthcare resource utilization outcomes in a stepped-wedge implementation study in 16 hospital emergency departments (EDs) across the Intermountain Healthcare integrated health system.
Since the launch of a paper-based pneumonia care process model in 1994, decision support for
pneumonia care has been under continuous development at Intermountain. Studies published in
2001 and 2006 demonstrated decreased mortality using paper-based methods. An electronic
pneumonia Clinical Decision Support System was later developed in the original Intermountain
computing environment and implemented in 4 regional emergency departments (ED) in 2011. This
tool featured a novel mortality predictor and real-time synthesis of clinical data to guide
diagnosis, risk stratification, admission triage and guideline-concordant treatment. An
outcome study published in 2015 demonstrated reduction in mortality with tool use compared to
usual care. Most recently, Intermountain researchers led by study co-Investigator, Dr.
Brandon Webb, developed an innovative tool to predict risk of drug-resistant bacteria and
demonstrated its potential to improve antibiotic use and outcomes.
The investigators have entered a robust phase of additional development and adaptation of
ePneumonia into the Cerner Electronic Health Record (EHR) system. The objective of this study
is to advance development of an evidence-based, electronic CDSS for pneumonia care with
interoperability across EHRs in order to improve clinical outcomes and reduce healthcare
resource utilization. The specific aim of this study is to evaluate the usability of
ePneumonia and its associated impact on clinical, patient-centered and healthcare resource
utilization outcomes in a stepped-wedge implementation study in 16 hospital EDs in the
Intermountain Healthcare integrated health system.
- Hypothesis #1: Healthcare providers will affirm ePneumonia usability, lack of
interference with clinical workflow and only minor unintended consequences of use.
- Hypothesis #2: In patients with community-onset pneumonia, ePneumonia use will improve
clinical and patient-centered outcomes and decrease healthcare resource utilization.
One year of baseline clinical outcome data will be gathered for all 16 emergency departments.
The first of 6 clusters of ED's will begin prospective data collection in January 2018, with
the remaining coming on at 2 month intervals until ePneumonia has been deployed at all sites.
An additional 1 year of data collection will be continued through 2019.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04244474 -
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
|
Phase 1/Phase 2 | |
| Completed |
NCT05815264 -
Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Chinese Population Aged 2 Years and Above
|
Phase 1 | |
| Recruiting |
NCT04589936 -
Prone Position to Improve Oxygenation in COVID-19 Patients Outside Critical Care
|
N/A | |
| Completed |
NCT02905383 -
The Effect of Exercise on Physical Function and Health in Older People After Discharge From Hospital
|
N/A | |
| Completed |
NCT06210737 -
A Study to Evaluate Persistence of Immunity of PCV13 in Healthy Population Aged 2 Months，7 Months-5 Years
|
Phase 4 | |
| Terminated |
NCT03944551 -
Bubble Continuous Positive Airway Pressure for Children With Severe Pneumonia in Mali, Africa
|
N/A | |
| Terminated |
NCT04660084 -
Impact of Molecular Testing on Improved Diagnosis, Treatment and Management of CAP
|
N/A | |
| Not yet recruiting |
NCT05649891 -
Checklists Resuscitation Emergency Department
|
N/A | |
| Withdrawn |
NCT05702788 -
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
|
Phase 2 | |
| Not yet recruiting |
NCT04171674 -
Pharmacokinetics of High-dose Ceftobiprole in Community-acquired Pneumonia Under Mechanical Ventilation.
|
N/A | |
| Active, not recruiting |
NCT03140163 -
Screening for Pneumonia: A Comparison of Ultra Low Dose Chest CT [ULD-CT] and Conventional Chest Radiography [CXR]
|
N/A | |
| Completed |
NCT02864420 -
Hospitalization at Home: The Acute Care Home Hospital Program for Adults
|
N/A | |
| Completed |
NCT02638649 -
Prehospital Use of Ultrasound in Undifferentiated Shortness of Breath
|
||
| Recruiting |
NCT02515565 -
Physiotherapy in Patients Hospitalized Due to Pneumonia.
|
N/A | |
| Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
| Completed |
NCT01446926 -
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants
|
Phase 1 | |
| Completed |
NCT01399723 -
Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia
|
Phase 3 | |
| Completed |
NCT01416519 -
Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation
|
N/A | |
| Completed |
NCT01416506 -
Community-Acquired Pneumonia (CAP) Surveillance
|
N/A | |
| Terminated |
NCT02358642 -
Drug to Prevent Pneumonia in the Tube Fed
|
Phase 4 |